FDA NDC Directory · JSON-LD · Markdown

LACOSAMIDE

NDC 31722-203 · HUMAN PRESCRIPTION DRUG · INJECTION

Labeler / ManufacturerCamber Pharmaceuticals, Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA216335
Dosage form / routeINJECTION · INTRAVENOUS
Active ingredientsLACOSAMIDE (10 mg/mL)
Marketing started20220914
Package count2

External sources

Source: openFDA. Public-domain (CC0).